 |
|
|
The Department of Biomedical Engineering at the University of Virginia was established in 1967 as a joint program of U.Va.'s School of Medicine and School of Engineering and Applied Science. Today, everyone from prospective students to ABET accreditors takes note of BME's true dual culture in Engineering and Medicine, which is almost unique to U.Va. It's one reason why the Provost's Office has identified Biomedical Engineering – U.Va.'s top-ranked science or engineering program – as a strength to sustain in its Strategic Directions for the University of Virginia.
Our department is home to a Wallace H. Coulter Foundation Translational Partnership Award , which draws on the joint strengths of the U.Va. School of Engineering, School of Medicine, Darden School of Business, and Health Sciences Center.
|
|
|
|
|
|
 |
|
Center for Innovative Technology (CIT) recently announced its grant awards for Fall 2011.
Several Coulter funded start-up companies were awarded funds through the Commonwealth Commercialization Research Fund.
- HemoSonics, LLC - $100,000 in SBIR matching funds
- iTi Health, Inc., - $100,000 in SBIR matching funds
- HemoShear, LLC - $500,000 through the commercialization program
- RetiVue, LLC - $250,000 through the commercialization program
The grants awarded were part of the $3.6 million that CIT distributed to start-up companies in Virginia this year. More information on the awards is available here. More...
UVa BME is #11 in National Research Council Rankings
UVa BME is the #11 bioengineering doctoral program in the nation, occupying a tight band of competition among East Coast rivals Duke, Johns Hopkins, U-Penn, and Georgia Tech, says the National Research Council. More...
[ More News ] |
|
|
 |
|
|
